Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Daily News

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Shelley Wood

February 19, 2024

News Daily News

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Yael L. Maxwell

January 22, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

Michael O'Riordan

September 13, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Daily News

Even in Big Cities, There Are Barriers to TAVI Access

Caitlin E. Cox

November 17, 2021

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News SCAI 2021

As Market Forces Drive TAVI Access, Rural Patients Left Behind

Michael O'Riordan

April 29, 2021

News Daily News

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

Caitlin E. Cox

April 05, 2021

News Daily News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Michael O'Riordan

January 22, 2020

News Daily News

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

Caitlin E. Cox

October 02, 2019

News Daily News

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

Michael O'Riordan

August 06, 2018

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

Advertisement

CVD Still the Leading Cause of Death and Disease Globally

ESC/EACTS Release New Valvular Heart Disease Guidelines

August 2024 Dispatch for the CV Team

June 2024 Dispatch for the CV Team

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

January 2024 Dispatch for the CV Team

October 2023 News Roundup

Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes

June 2022 News Roundup

Even in Big Cities, There Are Barriers to TAVI Access

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

As Market Forces Drive TAVI Access, Rural Patients Left Behind

TAVI Matches SAVR in Older US Patients With Rheumatic Aortic Stenosis

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Drug Abuse in Infective Endocarditis Patients Spikes Amid US Opioid Epidemic

‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content